36
Participants
Start Date
November 30, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
June 30, 2008
50 microgram antigen (Ag85B + ESAT-6)
0.5 mL suspension for injection x 2 with 2 months interval
50 microgram antigen (Ag85B + ESAT-6) + 100 nmol KLK + 4 nmol ODN1a
0.5 mL suspension for injection x 2 with 2 months interval
50 microgram antigen (Ag85B + ESAT-6) + 500 nmol KLK + 20 nmol ODN1a
0.5 mL suspension for injection x 2 with 2 months interval
Leiden University Medical Centre, Leiden
Statens Serum Institut
OTHER